Andromeda Surgical raises $15m Series A for commercial launch
Standard Capital leads the surgical robotics financing as Andromeda prepares hospital deployments and expands utilization.
Financing a commercial launch
Andromeda Surgical raised a $15 million Series A led by Standard Capital, bringing total funding to $30 million. The company said the round would fund commercial launch and scale-up. Its announcement named Y Combinator, VOX Capital, Lingotto Innovation, Cybernetix Ventures, NZVC, WestWave Capital, Zelda Ventures, Alumni Ventures, Rebel Fund, Zeno Partners and Techable VC among the participants.
From clinical use to hospital deployment
At the announcement, Andromeda reported more than 40 prostate-enucleation procedures across three countries and clearance to launch in Canada and New Zealand. It expected its first commercial systems to enter hospitals within two months, with plans to increase utilization, broaden procedures and add autonomous capabilities. Existing investor Phaze Ventures separately confirmed its participation. JSK Investments SICAV subsequently announced its Series A investment in September.